𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PROINFLAMMATORY AND “RESILIENCY” PROTEINS IN THE CSF OF PATIENTS WITH MAJOR DEPRESSION

✍ Scribed by Jose M. Martinez; Amir Garakani; Rachel Yehuda; Jack M. Gorman

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
479 KB
Volume
29
Category
Article
ISSN
1091-4269

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Factor structure of the hospital anxiety
Factor structure of the hospital anxiety and depression scale in older patients with major depression
✍ Alastair J. Flint; Sandra L. Rifat 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 1 views

## Abstract ## Objective Symptomatic anxiety has prognostic significance in major depression. In theory, the Hospital Anxiety and Depression Scale (HADS) should be a useful instrument for measuring the severity of symptomatic anxiety in late‐life depression. However, the dimensional structure of t

Comparison of pramipexole, fluoxetine, a
Comparison of pramipexole, fluoxetine, and placebo in patients with major depression
✍ Mark H. Corrigan; Angelita Q. Denahan; C. Eugene Wright; Rhonda J. Ragual; Dwigh 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB 👁 2 views

Pramipexole, a dopamine D 2 receptor agonist, was tested in 174 patients with major depression, with or without melancholia and without psychotic features. Three daily dose levels (0.375 mg, 1.0 mg, and 5.0 mg) were compared to fluoxetine (Prozac) at 20 mg and placebo in a randomized, double-blind,

Predictors of response to sertraline in
Predictors of response to sertraline in patients with major depression
✍ Shigeru Morishita; Toshihiko Kinoshita 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 1 views

## Abstract ## Objective Investigation of the characteristics of patients being treated with antidepressants would be useful in determining which patients would most likely benefit from antidepressant. The purpose of this study was to examine the possible predictors of response to sertraline in ma

Bupropion SR in the naturalistic treatme
Bupropion SR in the naturalistic treatment of elderly patients with major depression
✍ David C. Steffens; P. Murali Doraiswamy; Douglas R. McQuoid 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB 👁 1 views

## Abstract ## Introduction Bupropion immediate release (IR) and bupropion sustained release (SR) are frequently used to treat geriatric depression, as they have few cardiovascular, gastrointestinal and sexual adverse effects. We sought to examine the efficacy and dosing patterns of bupropion in a

Trajectories of mobility and IADL functi
Trajectories of mobility and IADL function in older patients diagnosed with major depression
✍ Celia F. Hybels; Carl F. Pieper; Dan G. Blazer; Gerda G. Fillenbaum; David C. St 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 1 views

## Abstract ## Objective Research has shown an association between depression and functional limitations in older adults. Our aim was to explore the latent traits of trajectories of limitations in mobility and instrumental activities of daily living (IADL) tasks in a sample of older adults diagnos